Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase
- PMID: 34455933
- DOI: 10.1080/07391102.2021.1970024
Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase
Abstract
The rise in the incidence of COVID-19 as a result of SARS-CoV-2 infection has threatened public health globally. Till now, there have been no proper prophylactics available to fight COVID-19, necessitating the advancement and evolution of effective curative against SARS-CoV-2. This study aimed at the nonstructural protein 13 (nsp13) helicase as a promising target for drug development against COVID-19. A unique collection of nucleoside analogs was screened against the SARS-CoV-2 helicase protein, for which a molecular docking experiment was executed to depict the selected ligand's binding affinity with the SARS-CoV-2 helicase proteins. Simultaneously, molecular dynamic simulations were performed to examine the protein's binding site's conformational stability, flexibility, and interaction with the ligands. Key nucleoside ligands were selected for pharmacokinetic analysis based on their docking scores. Selected ligands (cordycepin and pritelivir) showed excellent pharmacokinetics and were well stabilized at the proteins' binding site throughout the MD simulation. We have also performed binding free energy analysis or the binding characteristics of ligands with Nsp13 by using MM-PBSA and MM-GBSA. Free energy calculation by MM-PBSA and MM-GBSA analysis suggests that pritelivir may work as viable therapeutics for efficient drug advancement against SARS-CoV-2 Nsp13 helicase, potentially arresting the SARS-CoV-2 replication.Communicated by Ramaswamy H. Sarma.
Keywords: ADMET; SARS-CoV-2; helicase; molecular docking; nsp13; simulation and free energy.
Similar articles
-
Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of invitro studies.J Virus Erad. 2023 Jun;9(2):100327. doi: 10.1016/j.jve.2023.100327. Epub 2023 May 26. J Virus Erad. 2023. PMID: 37363132 Free PMC article. Review.
-
Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.Mol Divers. 2022 Feb;26(1):429-442. doi: 10.1007/s11030-021-10251-1. Epub 2021 Jun 12. Mol Divers. 2022. PMID: 34117992 Free PMC article.
-
In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.Int J Mol Sci. 2023 Mar 7;24(6):5120. doi: 10.3390/ijms24065120. Int J Mol Sci. 2023. PMID: 36982188 Free PMC article.
-
In silico Identification of Novel SARS-CoV-2 Main Protease and Nonstructural Protein 13 (nsp13) Inhibitors through Consensus Docking and Free Binding Energy Calculations.Comb Chem High Throughput Screen. 2023;26(6):1242-1250. doi: 10.2174/1386207325666220818141112. Comb Chem High Throughput Screen. 2023. PMID: 35984023
-
Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors.J Enzyme Inhib Med Chem. 2022 Dec;37(1):563-572. doi: 10.1080/14756366.2021.2022659. J Enzyme Inhib Med Chem. 2022. PMID: 35012384 Free PMC article.
Cited by
-
Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding.Sci Rep. 2023 Mar 4;13(1):3643. doi: 10.1038/s41598-023-30095-z. Sci Rep. 2023. PMID: 36871056 Free PMC article.
-
SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1.Cell Biosci. 2022 Mar 22;12(1):36. doi: 10.1186/s13578-022-00770-1. Cell Biosci. 2022. PMID: 35317858 Free PMC article.
-
Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase.Int J Mol Sci. 2022 Jul 12;23(14):7704. doi: 10.3390/ijms23147704. Int J Mol Sci. 2022. PMID: 35887049 Free PMC article.
-
Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of invitro studies.J Virus Erad. 2023 Jun;9(2):100327. doi: 10.1016/j.jve.2023.100327. Epub 2023 May 26. J Virus Erad. 2023. PMID: 37363132 Free PMC article. Review.
-
Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis.Sci Rep. 2022 Apr 14;12(1):6241. doi: 10.1038/s41598-022-09845-y. Sci Rep. 2022. PMID: 35422113 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous